{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:21:09Z","timestamp":1791991269722,"version":"4.4.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100013015","name":"Cedars-Sinai Medical Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013015","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s10620-024-08591-7","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T17:03:59Z","timestamp":1729616639000},"page":"4167-4177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Progression of Crohn\u2019s Disease in Newly Diagnosed Patients: Results from an Observational Study Using US Claims Data"],"prefix":"10.1007","volume":"69","author":[{"given":"Yanni","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negar","family":"Omidakhsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda L.","family":"Bohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Putnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Shola","family":"Adewale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil Y.","family":"Melmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,22]]},"reference":[{"key":"8591_CR1","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/S0140-6736(12)60026-9","volume":"380","author":"DC Baumgart","year":"2012","unstructured":"Baumgart DC, Sandborn WJ. Crohn\u2019s disease. Lancet. 2012;380:1590\u20131605.","journal-title":"Lancet."},{"key":"8591_CR2","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.3748\/wjg.v18.i29.3790","volume":"18","author":"G Latella","year":"2012","unstructured":"Latella G, Papi C. Crucial steps in the natural history of inflammatory bowel disease. World J Gastroenterol. 2012;18:3790\u20133799.","journal-title":"World J Gastroenterol."},{"key":"8591_CR3","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1111\/j.1572-0241.2008.02212.x","volume":"103","author":"KM Tarrant","year":"2008","unstructured":"Tarrant KM, Barclay ML, Frampton CM, Gearry RB. Perianal disease predicts changes in Crohn\u2019s disease phenotype-results of a population-based study of inflammatory bowel disease phenotype. Am J Gastroenterol. 2008;103:3082\u20133093.","journal-title":"Am J Gastroenterol."},{"key":"8591_CR4","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/gut.49.6.777","volume":"49","author":"E Louis","year":"2001","unstructured":"Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J. Behaviour of Crohn\u2019s disease according to the Vienna classification: changing pattern over the course of the disease. Gut. 2001;49:777\u2013782.","journal-title":"Gut."},{"key":"8591_CR5","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.cgh.2007.09.002","volume":"5","author":"IC Solberg","year":"2007","unstructured":"Solberg IC, Vatn MH, Hoie O et al. Clinical course in Crohn\u2019s disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol. 2007;5:1430\u20131438.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"8591_CR6","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1053\/j.gastro.2010.06.070","volume":"139","author":"KT Thia","year":"2010","unstructured":"Thia KT, Sandborn WJ, Harmsen WS, Zinsmeister AR, Loftus EV Jr. Risk factors associated with progression to intestinal complications of Crohn\u2019s disease in a population-based cohort. Gastroenterology. 2010;139:1147\u20131155.","journal-title":"Gastroenterology."},{"key":"8591_CR7","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/00054725-200207000-00002","volume":"8","author":"J Cosnes","year":"2002","unstructured":"Cosnes J, Cattan S, Blain A et al. Long-term evolution of disease behavior of Crohn\u2019s disease. Inflamm Bowel Dis. 2002;8:244\u2013250.","journal-title":"Inflamm Bowel Dis."},{"key":"8591_CR8","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1136\/gutjnl-2012-304353","volume":"62","author":"F Rieder","year":"2013","unstructured":"Rieder F, Zimmermann EM, Remzi FH, Sandborn WJ. Crohn\u2019s disease complicated by strictures: a systematic review. Gut. 2013;62:1072\u20131084.","journal-title":"Gut."},{"key":"8591_CR9","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1136\/gut.2009.202101","volume":"59","author":"AV Ramadas","year":"2010","unstructured":"Ramadas AV, Gunesh S, Thomas GA, Williams GT, Hawthorne AB. Natural history of Crohn\u2019s disease in a population-based cohort from Cardiff (1986\u20132003): a study of changes in medical treatment and surgical resection rates. Gut. 2010;59:1200\u20131206.","journal-title":"Gut."},{"key":"8591_CR10","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1136\/gut.2005.084061","volume":"55","author":"FL Wolters","year":"2006","unstructured":"Wolters FL, Russel MG, Sijbrandij J et al. Phenotype at diagnosis predicts recurrence rates in Crohn\u2019s disease. Gut. 2006;55:1124\u20131130.","journal-title":"Gut."},{"key":"8591_CR11","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/ecco-jcc\/jjz131","volume":"14","author":"JF Colombel","year":"2020","unstructured":"Colombel JF, D\u2019Haens G, Lee WJ, Petersson J, Panaccione R. Outcomes and strategies to support a treat-to-target approach in inflammatory bowel disease: a systematic review. J Crohns Colitis. 2020;14:254\u2013266.","journal-title":"J Crohns Colitis."},{"key":"8591_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/ecco-jcc\/jjz180","volume":"14","author":"J Torres","year":"2020","unstructured":"Torres J, Bonovas S, Doherty G et al. ECCO Guidelines on therapeutics in Crohn\u2019s disease: medical treatment. J Crohns Colitis. 2020;14:4\u201322.","journal-title":"J Crohns Colitis."},{"key":"8591_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/apt.13847","volume":"45","author":"EJ Mao","year":"2017","unstructured":"Mao EJ, Hazlewood GS, Kaplan GG, Peyrin-Biroulet L, Ananthakrishnan AN. Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn\u2019s disease and ulcerative colitis. Aliment Pharmacol Ther. 2017;45:3\u201313.","journal-title":"Aliment Pharmacol Ther."},{"key":"8591_CR14","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1136\/gutjnl-2017-315568","volume":"68","author":"J Burisch","year":"2019","unstructured":"Burisch J, Kiudelis G, Kupcinskas L et al. Natural disease course of Crohn\u2019s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study. Gut. 2019;68:423\u2013433.","journal-title":"Gut."},{"key":"8591_CR15","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1007\/s00384-021-03930-w","volume":"36","author":"C St\u00f6ss","year":"2021","unstructured":"St\u00f6ss C, Berlet M, Reischl S et al. Crohn\u2019s disease: a population-based study of surgery in the age of biological therapy. Int J Colorectal Dis. 2021;36:2419\u20132426.","journal-title":"Int J Colorectal Dis."},{"key":"8591_CR16","unstructured":"Optum. Market clarity: linked EHR and claims data, 2024. Available at: https:\/\/www.optum.com\/business\/life-sciences\/real-world-data\/market-clarity-data.html. Accessed Jan 9, 2024."},{"key":"8591_CR17","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1093\/ibd\/izab327","volume":"28","author":"L Yao","year":"2022","unstructured":"Yao L, Chen H, Shao B et al. Temporal changes in the treatment paradigm and long-term prognosis of patients with Crohn\u2019s disease: a hospital-based cohort study in China. Inflamm Bowel Dis. 2022;28:S25\u2013S34.","journal-title":"Inflamm Bowel Dis."},{"key":"8591_CR18","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/ecco-jcc\/jjx138","volume":"12","author":"B Lo","year":"2018","unstructured":"Lo B, Vester-Andersen MK, Vind I et al. Changes in disease behaviour and location in patients with Crohn\u2019s disease after seven years of follow-up: a Danish population-based inception cohort. J Crohns Colitis. 2018;12:265\u2013272.","journal-title":"J Crohns Colitis."},{"key":"8591_CR19","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.3748\/wjg.v19.i14.2217","volume":"19","author":"BD Lovasz","year":"2013","unstructured":"Lovasz BD, Lakatos L, Horvath A et al. Evolution of disease phenotype in adult and pediatric onset Crohn\u2019s disease in a population-based cohort. World J Gastroenterol. 2013;19:2217\u20132226.","journal-title":"World J Gastroenterol."},{"key":"8591_CR20","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.cgh.2020.08.022","volume":"19","author":"N Plevris","year":"2021","unstructured":"Plevris N, Fulforth J, Lyons M et al. Normalization of fecal calprotectin within 12 months of diagnosis is associated with reduced risk of disease progression in patients with Crohn\u2019s disease. Clin Gastroenterol Hepatol. 2021;19:1835\u20131844.e6.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"8591_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00054725-200002000-00002","volume":"6","author":"C Gasche","year":"2000","unstructured":"Gasche C, Scholmerich J, Brynskov J et al. A simple classification of Crohn\u2019s disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 2000;6:8\u201315.","journal-title":"Inflamm Bowel Dis."},{"key":"8591_CR22","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gut.2005.082909","volume":"55","author":"J Satsangi","year":"2006","unstructured":"Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749\u2013753.","journal-title":"Gut."},{"key":"8591_CR23","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.3390\/ijms19082244","volume":"19","author":"SO Adegbola","year":"2018","unstructured":"Adegbola SO, Sahnan K, Warusavitarne J, Hart A, Tozer P. Anti-TNF therapy in Crohn\u2019s disease. Int J Mol Sci. 2018;19:2244.","journal-title":"Int J Mol Sci."},{"key":"8591_CR24","unstructured":"Centocor Inc. Remicade\u2122 (infliximab) for IV injection, 1998. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/1998\/inflcen082498lb.pdf. Accessed Feb 27, 2024."},{"key":"8591_CR25","unstructured":"Takeda Pharmaceuticals USA Inc. Entyvio\u00ae (vedolizumab) Prescribing Information, 2014. Available at: https:\/\/content.takeda.com\/?contenttype=PI&product=ENTY&language=ENG&country=USA&documentnumber=1. Accessed Feb 27, 2024."},{"key":"8591_CR26","unstructured":"Janssen Biotech Inc. Stelara\u00ae (ustekinumab) Prescribing Information, 2016. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/761044lbl.pdf. Accessed Aug 22, 2024."},{"key":"8591_CR27","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/ajg.2016.524","volume":"112","author":"SF Jeuring","year":"2017","unstructured":"Jeuring SF, van den Heuvel TR, Liu LY et al. Improvements in the long-term outcome of Crohn\u2019s disease over the past two decades and the relation to changes in medical management: results from the population-based IBDSL cohort. Am J Gastroenterol. 2017;112:325\u2013336.","journal-title":"Am J Gastroenterol."},{"key":"8591_CR28","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1093\/ecco-jcc\/jjad117","volume":"17","author":"L Gonczi","year":"2023","unstructured":"Gonczi L, Lakatos L, Golovics PA et al. Declining trends of reoperations and disease behavior progression in Crohn\u2019s disease over different therapeutic eras\u2014a prospective population-based study from western Hungary between 1977\u20132020, data from the Veszprem cohort. J Crohns Colitis. 2023;17:1980\u20131987.","journal-title":"J Crohns Colitis."},{"key":"8591_CR29","doi-asserted-by":"publisher","first-page":"7272","DOI":"10.3748\/wjg.v21.i23.7272","volume":"21","author":"PA Golovics","year":"2015","unstructured":"Golovics PA, Lakatos L, Mandel MD et al. Prevalence and predictors of hospitalization in Crohn\u2019s disease in a prospective population-based inception cohort from 2000\u20132012. World J Gastroenterol. 2015;21:7272\u20137280.","journal-title":"World J Gastroenterol."},{"key":"8591_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/MIB.0000000000000977","volume":"23","author":"BB Rao","year":"2017","unstructured":"Rao BB, Click BH, Koutroubakis IE et al. The cost of Crohn\u2019s disease: varied health care expenditure patterns across distinct disease trajectories. Inflamm Bowel Dis. 2017;23:107\u2013115.","journal-title":"Inflamm Bowel Dis."},{"key":"8591_CR31","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1080\/00365521.2018.1503709","volume":"53","author":"C Arieira","year":"2018","unstructured":"Arieira C, Curdia Goncaves T, de Castro FD, Joao Moreira M, Cotter J. Clinical course in Crohn\u2019s disease: factors associated with behaviour change and surgery. Scand J Gastroenterol. 2018;53:1222\u20131227.","journal-title":"Scand J Gastroenterol."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08591-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-024-08591-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08591-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T13:04:30Z","timestamp":1731675870000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-024-08591-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,22]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["8591"],"URL":"https:\/\/doi.org\/10.1007\/s10620-024-08591-7","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,22]]},"assertion":[{"value":"7 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"YF, LZ, and ASA are employees of Boehringer Ingelheim. NO is an employee of Bohn Epidemiology and has served as a consultant to Boehringer Ingelheim. RLB is the founder of Bohn Epidemiology and has served as a consultant to Boehringer Ingelheim. KP is a consultant for Bohn Epidemiology and has no disclosures to report. GYM reports receiving grants from Pfizer; consulting fees from AbbVie, Arena, Bristol Myers Squibb, Boehringer Ingelheim, Dieta, Entasis, Ferring, Fresenius Kabi, Janssen, Lilly, Medtronic, Oshi Health, Pfizer, Samsung Bioepis, Shionogi, Takeda, TechLab, and Viatris.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Optum is compliant with the Health Insurance Portability and Accountability Act of 1996 and does not include any patient-identifiable health information. Therefore, approval from an institutional review board was not required for this study. All patient data were anonymized and de-identified; therefore, informed consent was not necessary.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}}]}}